Literature DB >> 31565818

Acute enhancement of necrotic radio-frequency ablation lesions in left atrium and pulmonary vein ostia in swine model with non-contrast-enhanced T1 -weighted MRI.

Michael A Guttman1, Susumu Tao1, Sarah Fink1, Rick Tunin1, Ehud J Schmidt1, Daniel A Herzka2, Henry R Halperin1,3, Aravindan Kolandaivelu1.   

Abstract

PURPOSE: To evaluate non-contrast-enhanced MRI of acute radio-frequency ablation (RFA) lesions in the left atrium (LA) and pulmonary vein (PV) ostia. The goal is to provide a method for discrimination between necrotic (permanent) lesions and reversible injury, which is associated with recurrence after treatment of atrial fibrillation.
METHODS: Fifteen normal swine underwent RFA around the right-superior PV ostia. Electrical pulmonary vein isolation (PVI) was verified by electro-anatomic mapping (EAM) and pacing. MRI was carried out using a 3D respiratory-gated T1 -weighted long inversion time (TWILITE) sequence without contrast agent. Key settings were: inversion time 700 ms, triggering over 2 cardiac cycles, pixel size 1.1 mm3 . Contrast-enhanced imaging and T2 -weighted imaging were carried out for comparison. Six animals were sacrificed on ablation day for TTC-stained gross pathology, 9 animals were sacrificed after 2-3 mo after repeat EAM and MRI. Image intensity ratio (IIR) was used to measure lesion enhancement, and gross pathology was used to validate image enhancement patterns and compare lesion widths.
RESULTS: RFA lesions exhibited unambiguous enhancement in acute TWILITE imaging (IIR = 2.34 ± 0.49 at 1.5T), and the enhancement patterns corresponded well with gross pathology. Lesion widths in MRI correlated well with gross pathology (R2 = 0.84), with slight underestimation by 0.9 ± 0.5 mm. Lesion enhancement subsided chronically.
CONCLUSION: TWILITE imaging allowed acute detection of permanent RFA lesions in swine LA and PV ostia, without the need for contrast agent. Lesion enhancement pattern showed good correspondence to gross pathology and was well visualized by volume rendering. This method may provide valuable intra- or post-procedural assessment of RFA treatment.
© 2019 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  T1-weighted radiofrequency ablation; atrial arrhythmia; left atrium; lesion gaps; magnetic resonance imaging; non-contrast-enhanced; pulmonary vein isolation; recurrence

Mesh:

Year:  2019        PMID: 31565818      PMCID: PMC6949368          DOI: 10.1002/mrm.28001

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  50 in total

1.  Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla.

Authors:  Gaston R Vergara; Sathya Vijayakumar; Eugene G Kholmovski; Joshua J E Blauer; Mike A Guttman; Christopher Gloschat; Gene Payne; Kamal Vij; Nazem W Akoum; Marcos Daccarett; Christopher J McGann; Rob S Macleod; Nassir F Marrouche
Journal:  Heart Rhythm       Date:  2010-10-27       Impact factor: 6.343

Review 2.  The biophysics of radiofrequency catheter ablation in the heart: the importance of temperature monitoring.

Authors:  D E Haines
Journal:  Pacing Clin Electrophysiol       Date:  1993-03       Impact factor: 1.976

3.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; José Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  Heart Rhythm       Date:  2012-03-01       Impact factor: 6.343

4.  Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging.

Authors:  J N Oshinski; Z Yang; J R Jones; J F Mata; B A French
Journal:  Circulation       Date:  2001-12-04       Impact factor: 29.690

5.  CMR-guided approach to localize and ablate gaps in repeat AF ablation procedure.

Authors:  Felipe Bisbal; Esther Guiu; Pilar Cabanas-Grandío; Antonio Berruezo; Susana Prat-Gonzalez; Bárbara Vidal; Cesar Garrido; David Andreu; Juan Fernandez-Armenta; Jose María Tolosana; Elena Arbelo; Teresa M de Caralt; Rosario J Perea; Josep Brugada; Lluís Mont
Journal:  JACC Cardiovasc Imaging       Date:  2014-05-07

6.  Temporal left atrial lesion formation after ablation of atrial fibrillation.

Authors:  Troy J Badger; Robert S Oakes; Marcos Daccarett; Nathan S Burgon; Nazem Akoum; Eric N Fish; Joshua J E Blauer; Swati N Rao; Yaw Adjei-Poku; Eugene G Kholmovski; Sathya Vijayakumar; Edward V R Di Bella; Rob S MacLeod; Nassir F Marrouche
Journal:  Heart Rhythm       Date:  2008-11-06       Impact factor: 6.343

7.  Arrhythmia recurrence after atrial fibrillation ablation: can magnetic resonance imaging identify gaps in atrial ablation lines?

Authors:  Vivek Y Reddy; Ehud J Schmidt; Godtfred Holmvang; Maggie Fung
Journal:  J Cardiovasc Electrophysiol       Date:  2007-12-20

8.  Cardiac Magnetic Resonance for Lesion Assessment in the Electrophysiology Laboratory.

Authors:  Timothy M Markman; Saman Nazarian
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-11

9.  50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study.

Authors:  Renate B Schnabel; Xiaoyan Yin; Philimon Gona; Martin G Larson; Alexa S Beiser; David D McManus; Christopher Newton-Cheh; Steven A Lubitz; Jared W Magnani; Patrick T Ellinor; Sudha Seshadri; Philip A Wolf; Ramachandran S Vasan; Emelia J Benjamin; Daniel Levy
Journal:  Lancet       Date:  2015-05-07       Impact factor: 79.321

10.  Feasibility of real-time MR thermal dose mapping for predicting radiofrequency ablation outcome in the myocardium in vivo.

Authors:  Solenn Toupin; Pierre Bour; Matthieu Lepetit-Coiffé; Valéry Ozenne; Baudouin Denis de Senneville; Rainer Schneider; Alexis Vaussy; Arnaud Chaumeil; Hubert Cochet; Frédéric Sacher; Pierre Jaïs; Bruno Quesson
Journal:  J Cardiovasc Magn Reson       Date:  2017-01-25       Impact factor: 5.364

View more
  6 in total

1.  Left atrial evaluation by cardiovascular magnetic resonance: sensitive and unique biomarkers.

Authors:  Dana C Peters; Jérôme Lamy; Albert J Sinusas; Lauren A Baldassarre
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2021-12-18       Impact factor: 6.875

2.  Reduced motion external defibrillation: Reduced subject motion with equivalent defibrillation efficiency validated in swine.

Authors:  Ehud J Schmidt; Hassan Elahi; Eric S Meyer; Ryan Baumgaertner; Luca Neri; Ronald D Berger; Harikrishna Tandri; David W Hunter; Steven P Cohen; Matt T Oberdier; Henry R Halperin
Journal:  Heart Rhythm       Date:  2022-02-28       Impact factor: 6.779

3.  Intracardiac MR imaging (ICMRI) guiding-sheath with amplified expandable-tip imaging and MR-tracking for navigation and arrythmia ablation monitoring: Swine testing at 1.5 and 3T.

Authors:  Ehud J Schmidt; Gregory Olson; Junichi Tokuda; Akbar Alipour; Ronald D Watkins; Eric M Meyer; Hassan Elahi; William G Stevenson; Jeffrey Schweitzer; Charles L Dumoulin; Thomas Johnson; Aravindan Kolandaivelu; Wolfgang Loew; Henry R Halperin
Journal:  Magn Reson Med       Date:  2022-02-10       Impact factor: 3.737

4.  Active Tracking-based cardiac triggering for MR-thermometry during radiofrequency ablation therapy in the left ventricle.

Authors:  Ronald Mooiweer; Rainer Schneider; Axel Joachim Krafft; Katy Empanger; Jason Stroup; Alexander Paul Neofytou; Rahul K Mukherjee; Steven E Williams; Tom Lloyd; Mark O'Neill; Reza Razavi; Tobias Schaeffter; Radhouene Neji; Sébastien Roujol
Journal:  Front Cardiovasc Med       Date:  2022-08-25

5.  Interventional cardiac magnetic resonance imaging: current applications, technology readiness level, and future perspectives.

Authors:  Sophie C Rier; Suzan Vreemann; Wouter H Nijhof; Vincent J H M van Driel; Ivo A C van der Bilt
Journal:  Ther Adv Cardiovasc Dis       Date:  2022 Jan-Dec

Review 6.  Black-Blood Contrast in Cardiovascular MRI.

Authors:  Markus Henningsson; Shaihan Malik; Rene Botnar; Daniel Castellanos; Tarique Hussain; Tim Leiner
Journal:  J Magn Reson Imaging       Date:  2020-10-19       Impact factor: 5.119

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.